Diffuse large B-cell lymphoma is an aggressive malignant lymphoma that constitutes approximately 30%-40% of all cases of non-Hodgkin lymphoma (NHL), making it the most common type of lymphoma. While once considered to be a single disease entity, many distinct clinical and morphological variants are now recognized.[1] Additionally, over recent years, gene expression profiling and other molecular high resolution technologies have revealed that DLBCL is genetically heterogeneous. According to gene expression profiling, most cases can be divided into one of two major molecular subtypes, according to their cell of origin (COO) - a germinal center B-cell (GCB) subtype or an activated B-cell (ABC) subtype.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2s2vjSg
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Bromodomain proteins function as epigenetic readers that recognize acetylated histone tails to facilitate the transcription of t...
-
Objectives To optimise medical students’ early clerkship is a complex task since it is conducted in a context primarily organised to take ca...
-
Abstract Purpose Overcoming the flaws of current data management conditions in head and neck oncology could enable integrated informatio...
-
C. Julian Chen'Correspondence information about the author C. Julian ChenEmail the author C. Julian Chen, Donald A. Miller DOI: https://...
-
ACS Nano DOI: 10.1021/acsnano.7b00032 from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2lNPpuk via...
-
Abstract Polychlorinated biphenyls (PCBs), a group of 209 congeners that differ in the number and position of chlorines on the biphenyl rin...
-
1 abqls-210rm.html Read the latest Journal of Clinical Neurophysiology - Vol. 37, No. 1, January 2020.eml 2 agx3v-nxz96.html Read the late...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου